Australia markets closed

ChemoCentryx, Inc. (CCXI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
25.06-1.58 (-5.93%)
At close: 04:00PM EST
24.56 -0.50 (-2.00%)
After hours: 07:58PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Total revenue
33,840
64,392
35,952
42,875
Operating expenses
Research development
85,446
77,882
70,276
62,736
Selling general and administrative
68,270
42,186
24,155
20,409
Total operating expenses
153,289
119,569
94,255
83,145
Operating income or loss
-119,449
-55,177
-58,303
-40,270
Interest expense
2,752
2,643
2,149
1,224
Total other income/expenses net
-
-179
2,814
2,304
Income before tax
-121,103
-55,356
-55,489
-37,966
Income from continuing operations
-121,103
-55,356
-55,489
-37,966
Net income
-121,103
-55,356
-55,489
-37,966
Net income available to common shareholders
-121,103
-55,356
-55,489
-37,966
Basic EPS
-
-0.84
-0.98
-0.76
Diluted EPS
-
-0.84
-0.98
-0.76
Basic average shares
-
65,688
56,898
49,814
Diluted average shares
-
65,688
56,898
49,814
EBITDA
-
-51,916
-51,698
-36,230